33 results about "Radiographic Contrast Agent" patented technology

The invention belongs to the technical field of medical imaging, and discloses a gallium-based radioactive contrast agent with glycosylation-modified maltotriose covalently linked with a chelating group as well as a preparation method and application of the gallium-based radioactive contrast agent. The preparation method comprises the following steps: firstly, modifying a cyclic polydentate ligand, carrying out nucleophilic substitution, then connecting an upper half flexible chain or loop chain, and then carrying out glycosylation on acetyl protected maltotriose to connect a sugar part half flexible chain or loop chain; the preparation method comprises the following steps: preparing a polydentate ligand, carrying out reductive amination or urea condensation connection on aldehyde groups or aldehyde groups on half-chain end groups on two sides to form a whole, adding methanol and a sodium methoxide solution, removing acetyl of sugar, adding trifluoroacetic acid to remove protective groups on the polydentate ligand, and finally adding 68Ga for chelation to obtain a final product. And maltotriose is adopted as a guiding group, so that higher bacterial specificity and permeability are achieved, and the distinguishing degree in diagnosis of bacterial infection is higher.

The invention relates to the industrial preparation of non-ionic X-ray contrast agents. In particular, the present invention relates to a process for the synthesis of iopamidol using a continuous reactive extrusion process which enables efficient conversion of the relevant key intermediates, preferably in the absence of any solvent. The invention also relates to the preparation of radiographic X-ray contrast agents or key intermediates thereof by using reactive extrusion techniques.